These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31260581)

  • 1. Relationship between surgeons and industry.
    Jayne DG
    Br J Surg; 2019 Jul; 106(8):965-967. PubMed ID: 31260581
    [No Abstract]   [Full Text] [Related]  

  • 2. Genzyme-Sanofi buy out is second largest biotech deal ever.
    Ratner M
    Nat Biotechnol; 2011 Apr; 29(4):293-4. PubMed ID: 21478828
    [No Abstract]   [Full Text] [Related]  

  • 3. Do governance, equity characteristics, and venture capital nvolvement affect long-term wealth creation in U.S. health care and biotechnology IPOs?
    Williams DR; Duncan WJ; Ginter PM; Shewchuk RM
    J Health Care Finance; 2006; 33(1):54-71. PubMed ID: 21110493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 5. Accelerating the innovation cycle: a Boston model seeks solutions for lagging ingenuity in health care.
    Parrish JA; Schachter SC; Carleton PF; Dempsey M; Spilotis D; Collins J
    IEEE Pulse; 2014; 5(1):46-54. PubMed ID: 25296373
    [No Abstract]   [Full Text] [Related]  

  • 6. South Korean biotechnology--a rising industrial and scientific powerhouse.
    Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
    [No Abstract]   [Full Text] [Related]  

  • 7. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 8. The dilemma of professional and industry relations for medical education.
    DeMaria A; Oetgen WJ
    Eur Heart J; 2019 Apr; 40(16):1303-1305. PubMed ID: 30596988
    [No Abstract]   [Full Text] [Related]  

  • 9. Small company mergers--good for whom?
    Maybeck V; Bains W
    Nat Biotechnol; 2006 Nov; 24(11):1343-8. PubMed ID: 17093475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valuing inter-sectoral costs and benefits of interventions in the healthcare sector: methods for obtaining unit prices.
    Drost RM; Paulus AT; Ruwaard D; Evers SM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):77-84. PubMed ID: 26757960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences in the Medical Product Lifecycle.
    Whitty JA; de Bekker-Grob EW; Cook NS; Terris-Prestholt F; Drummond M; Falchetto R; Hillege HL
    Patient; 2020 Feb; 13(1):7-10. PubMed ID: 31782120
    [No Abstract]   [Full Text] [Related]  

  • 12. South Africa--blazing a trail for African biotechnology.
    Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683
    [No Abstract]   [Full Text] [Related]  

  • 13. The scientific muscle of Brazil's health biotechnology.
    Ferrer M; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC8-12. PubMed ID: 15583686
    [No Abstract]   [Full Text] [Related]  

  • 14. Building a business model in digital medicine.
    Steinberg D; Horwitz G; Zohar D
    Nat Biotechnol; 2015 Sep; 33(9):910-20. PubMed ID: 26348957
    [No Abstract]   [Full Text] [Related]  

  • 15. Bridging the gap from bench to bedside: China takes a new look at moving innovative health care ideas into the marketplace.
    Tang Y; Wang S; Wang Y; Xing X; Yu Y; Dong W
    IEEE Pulse; 2014; 5(1):55-8. PubMed ID: 25296374
    [No Abstract]   [Full Text] [Related]  

  • 16. Cuba--innovation through synergy.
    Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679
    [No Abstract]   [Full Text] [Related]  

  • 17. Omics-driven startups challenge healthcare model.
    Sheridan C
    Nat Biotechnol; 2015 Sep; 33(9):887-9. PubMed ID: 26348939
    [No Abstract]   [Full Text] [Related]  

  • 18. How Indian biotech is driving innovation.
    Nogrady B
    Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic data sharing: a new type of capital].
    Stoeklé HC; Forster N; Charlier P; Bloch OC; Hervé C; Turrini M; Vogt G
    Med Sci (Paris); 2018; 34(8-9):735-739. PubMed ID: 30230447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.